Prothena Corp (PRTA) to Present Update on NEOD001 Phase 1 Interim Data at XIV ISA
Tweet Send to a Friend
Prothena Corporation plc (Nasdaq: PRTA) announced that an abstract was published by the XIV International Symposium on Amyloidosis (ISA) and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE